US firm beefs up environmental, safety and health practice with group led by partners Peter Sellar and Gerard McElwee | 4mos
US firm beefs up environmental, safety and health practice with group led by partners Peter Sellar and Gerard McElwee | 4mos
Highly-regarded trial lawyer Allison Brown joins with four more partners | 4mos
Closure follows office head Shaobin Zhu defecting to DLA Piper last year | 4mos
Sarah Smith joins as head of Simmons’ UK competition and antitrust team following predecessor’s exit for Kirkland last year | 4mos
This second edition offers updated guidance on protecting brands against counterfeiting and the grey market, covering relevant legislation, enforcement measures and cross-border strategies in key jurisdictions around the world. | 7mos
Editor:
US firm's fourth European office to offer privacy and data security services to tech and life sciences clients | 5mos
Joiners arrive from Hausfeld, Pinsent Masons and Gowling WLG | 5mos
Patent litigator Alexander Ritter marks latest in string of European hires by the US firm | 5mos
Jones Day, Linklaters and Arnold & Porter also called in for the largest healthcare buyout of 2024 | 5mos
Results show EU Commission’s security initiative is having success in tackling counterfeits | 5mos
Firm says hire underscores commitment to strengthening UK IP practice | 6mos
Merged firm to house 230 professionals and operate under Venner Shipley name | 6mos
Laurence Lieberman led his former firm’s life sciences commercial disputes group | 7mos
Firm chair Alden Millard points to bolstering global M&A bench as a ‘priority’ | 7mos
Thomas Kendra brings emerging markets expertise to his new firm notably through his Africa work | 7mos
Jenny Davies joins as a partner in Cooley’s London life sciences partnering and licensing practice | 7mos
Californian court finds ‘strong likelihood’ that ex-employee took trade secret information to benefit his own company | 7mos
Latest lawsuits in mounting patent litigation over vaccines against the two viruses | 7mos
Arrival of Tim Powell continues US firm’s European IP push | 7mos
GSK’s two patents declared invalid as both attempt to launch first RSV vaccine in UK market | 8mos
Decisions from the European Patent Office and more recently the Unitary Patent Court continue to develop patent law affecting the life sciences in Europe, writes Mewburn Ellis patent lawyer Nick Sutcliffe | 8mos